A Phase I Trial of CCT303-406 in Patients With Relapsed or Refractory HER2 Positive Solid Tumors

Clinical trial NCT04511871 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04511871
Sponsor: Shanghai PerHum Therapeutics Co., Ltd.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor Gastric Cancer Breast Cancer Ovarian Cancer Sarcoma

Start date: 2020-07-09
Primary completion: 2024-10-24
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.